Rethinking lean metabolic dysfunction-associated steatotic liver disease: Unrecognized risk in lean populations: Editorial on “Normal-weight metabolic dysfunction-associated steatotic liver disease: Reclassification, characteristics, and adverse liver outcomes across diverse populations”
Abstract
Rethinking lean metabolic dysfunction-associated steatotic liver disease: Unrecognized risk in lean populations: Editorial on "Normal-weight metabolic dysfunction-associated steatotic liver disease: Reclassification, characteristics, and adverse liver outcomes across diverse populations"
Fields of Study & Subjects
Liver Disease Diagnosis and Treatment
Diabetes
Cardiovascular Risks
and Lipoproteins
Liver Disease and Transplantation
Publication details
- Journal / source
- Clinical and Molecular Hepatology
- Publisher
- The Korean Association for the Study of the Liver
- Volume
- 32
- Issue
- 3
- Pages
- 1441–1443
- Publication date
- 27 January 2026
- Language
- EN